SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant setting up Symtet facility at Bharuch SEZ

09 Mar 2011 Evaluate

Jubilant Lifesciences Ltd, an integrated pharma and lifesciences company, is setting up a manufacturing plant for Symtet with a capacity of 24,000 tonnes per annum and another one for chlorinated pyridine derivatives at its Bharuch special economic zone.The chlorinated pyridine plant would have a capacity of 5,000 tonnes per annum.

Symtet, also known as 2,3,5,6-Tetra Chloro Pyridine, is used in the manufacturing of Chlorpyrifos, one of the world’s largest and safest, low cost Insecticide that is clocking a growth of seven per cent globally. The facility is expected to be operational from Q4 FY2012 and will make Jubilant the largest producer of Symtet globally, catering to more than 40% of the worldwide demand. The company has already received approvals from major customers and is in the process of firming up long term arrangements with them. It expects to achieve additional annual revenue of $90 million from this facility.

The company has already set up two 10,000-tonne per annum (tpa) units each to make Niacinamide and 3-Cyanopyridine at its upcoming special economic zone (SEZ) at Bharuch in Gujarat. The company’s customer base is spread across 65 countries that include pharmaceutical, life sciences and agro-chemical companies. Its key markets are in North America, Europe and China.crackcrack

Jubilant Pharmova Share Price

965.65 -8.95 (-0.92%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: